Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1963 2
1966 1
1967 2
1968 3
1969 1
1970 3
1971 2
1972 1
1974 2
1975 1
1976 3
1977 1
1978 2
1979 5
1980 6
1981 12
1982 12
1983 9
1984 16
1985 24
1986 30
1987 20
1988 33
1989 31
1990 39
1991 35
1992 46
1993 38
1994 48
1995 53
1996 52
1997 53
1998 37
1999 54
2000 56
2001 68
2002 63
2003 54
2004 54
2005 76
2006 69
2007 86
2008 73
2009 86
2010 61
2011 54
2012 66
2013 81
2014 53
2015 63
2016 53
2017 75
2018 77
2019 80
2020 96
2021 78
2022 77
2023 74
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

2,198 results

Results by year

Filters applied: . Clear all
Page 1
Guidelines for the medical management of pediatric vesicoureteral reflux.
Miyakita H, Hayashi Y, Mitsui T, Okawada M, Kinoshita Y, Kimata T, Koikawa Y, Sakai K, Satoh H, Tokunaga M, Naitoh Y, Niimura F, Matsuoka H, Mizuno K, Kaneko K, Kubota M. Miyakita H, et al. Among authors: matsuoka h. Int J Urol. 2020 Jun;27(6):480-490. doi: 10.1111/iju.14223. Epub 2020 Apr 1. Int J Urol. 2020. PMID: 32239562 Free PMC article.
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.
Xu RH, Muro K, Morita S, Iwasa S, Han SW, Wang W, Kotaka M, Nakamura M, Ahn JB, Deng YH, Kato T, Cho SH, Ba Y, Matsuoka H, Lee KW, Zhang T, Yamada Y, Sakamoto J, Park YS, Kim TW. Xu RH, et al. Among authors: matsuoka h. Lancet Oncol. 2018 May;19(5):660-671. doi: 10.1016/S1470-2045(18)30140-2. Epub 2018 Mar 16. Lancet Oncol. 2018. PMID: 29555258 Clinical Trial.
Coping well.
Tu TTH, Toyofuku A, Matsuoka H. Tu TTH, et al. Among authors: matsuoka h. Br Dent J. 2020 Jul;229(2):70. doi: 10.1038/s41415-020-1931-x. Br Dent J. 2020. PMID: 32710019 Free PMC article. No abstract available.
[Masked hypertension].
Matsuoka H. Matsuoka H. Nihon Rinsho. 2014 Aug;72(8):1415-8. Nihon Rinsho. 2014. PMID: 25167745 Review. Japanese.
Postprandial microvascular dysfunction.
Matsuoka H. Matsuoka H. Circ J. 2009 Aug;73(8):1399-400. doi: 10.1253/circj.cj-09-0445. Circ J. 2009. PMID: 19628923 Free article. No abstract available.
Recent trends (2016-2017) in the treatment of inflammatory bowel disease.
Masaki T, Kishiki T, Kojima K, Asou N, Beniya A, Matsuoka H. Masaki T, et al. Among authors: matsuoka h. Ann Gastroenterol Surg. 2018 Jun 2;2(4):282-288. doi: 10.1002/ags3.12177. eCollection 2018 Jul. Ann Gastroenterol Surg. 2018. PMID: 30003191 Free PMC article. Review.
2,198 results